Johnson & Johnson agreed to pay a hefty settlement without admitting any product issues.


The recent highly publicized Johnson & Johnson talcum powder cancer case is about to come to an end. Although Johnson & Johnson does not admit there is an issue, they are willing to pay a substantial settlement fee.

Johnson & Johnson has agreed to pay $700 million to settle marketing investigations by 42 U.S. states and Washington, D.C., regarding its baby powder and other talc products, which were accused of causing cancer.

The settlement addresses allegations that Johnson & Johnson misled consumers into believing its talc products, sold for over a century, were safe, even though it stopped selling these products last year.

Johnson & Johnson, which did not admit to any wrongdoing in the settlement led by Florida, North Carolina, and Texas, stated that its talc products are safe and do not cause cancer. The company announced a settlement in principle in January.

"This is a significant step forward for consumer product safety," Florida Attorney General Ashley Moody said in a statement.

Johnson & Johnson still faces tens of thousands of talc-related lawsuits, including a class-action lawsuit alleging the company in New Brunswick, New Jersey, misled shareholders by concealing product risks.

As of March 31, about 61,490 people were still suing Johnson & Johnson, most of them women with ovarian cancer, with a smaller number suffering from asbestos-related mesothelioma.

Johnson & Johnson stopped selling talc-based baby powder worldwide last year and switched to cornstarch as the main ingredient, insisting that its products are asbestos-free.

The company twice attempted to resolve these lawsuits by placing a subsidiary under bankruptcy protection, but both attempts were rejected by the courts.

On May 1, Johnson & Johnson proposed a $6.48 billion settlement through a third bankruptcy filing to resolve most of the lawsuits. The company has set aside $11 billion in reserves to address all talc liabilities.

"The company continues to seek multiple avenues for a complete and final resolution of the talc litigation," Eric Haas, Johnson & Johnson's Vice President of Global Litigation, said in a statement on Tuesday.

"We will continue to address claims from those who do not wish to participate in our anticipated bankruptcy resolution through litigation or settlement," he added.



Risk Warning and Disclaimer

The market carries risks, and investment should be cautious. This article does not constitute personal investment advice and has not taken into account individual users' specific investment goals, financial situations, or needs. Users should consider whether any opinions, viewpoints, or conclusions in this article are suitable for their particular circumstances. Investing based on this is at one's own responsibility.

The End



Compensation refers to the act of providing economic restitution to the affected party by the defaulting party or the responsible party in the event of a breach, negligence, or other causes resulting in a loss to the other party in financial or commercial transactions.


Risk Warning

TraderKnows is a financial media platform, with information displayed coming from public networks or uploaded by users. TraderKnows does not endorse any trading platform or variety. We bear no responsibility for any trading disputes or losses arising from the use of this information. Please be aware that displayed information may be delayed, and users should independently verify it to ensure its accuracy.


Contact Us

Social Media